Literature DB >> 6973509

Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index.

C Andre, L Descos, P Landais, J Fermanian.   

Abstract

The ability of 11 laboratory parameters to reflect the degree of activity of Crohn's disease, using a clinical index as reference point was compared by means of multiple stepwise regression analysis. Activity was best defined in decreasing order by orosomucoid, sedimentation rate, C reactive protein, alpha-1-antitrypsin, albumin, haematocrit, IgM, circulating immune complexes, serum iron, IgG, and IgA. The haematocrit, the only laboratory measurement in the Crohn's disease activity index developed by the National Cooperative Study Group in the USA, is less discriminant than acute phase reactants. Only three parameters-namely, orosomucoid, sedimentation rate, and C reactive protein-have a significant weight and should be complementary to a simple clinical index.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6973509      PMCID: PMC1419331          DOI: 10.1136/gut.22.7.571

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  11 in total

1.  Cortisone in ulcerative colitis; final report on a therapeutic trial.

Authors:  S C TRUELOVE; L J WITTS
Journal:  Br Med J       Date:  1955-10-29

2.  Simple index of Crohn's disease activity.

Authors:  P R Elliott; J E Lennard-Jones; N Hathway
Journal:  Lancet       Date:  1980-04-19       Impact factor: 79.321

3.  A simple index of Crohn's-disease activity.

Authors:  R F Harvey; J M Bradshaw
Journal:  Lancet       Date:  1980-03-08       Impact factor: 79.321

4.  [How should one assess activity in Crohn's disease? Argument for a biological and clinical index. A cooperative study of the Research Group on Cryptogenetic Enterocolitis].

Authors:  C André; L Descos; M Cerf
Journal:  Gastroenterol Clin Biol       Date:  1979-11

5.  Uses and limitations of the Crohn's disease activity index.

Authors:  M Teixeira; A Ferguson
Journal:  Arq Gastroenterol       Date:  1979 Apr-Jun

6.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

7.  [Circulating immune complexes in man; precipitation of immune complexes with polyethylene glycol and their characterization by Clq bound to immunoglobulins].

Authors:  L Grangeot; J Pillot
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1975-03-03

8.  Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease.

Authors:  D P O'Donoghue; A M Dawson; J Powell-Tuck; R L Bown; J E Lennard-Jones
Journal:  Lancet       Date:  1978-11-04       Impact factor: 79.321

9.  An index of inflammatory activity in patients with Crohn's disease.

Authors:  P A van Hees; P H van Elteren; H J van Lier; J H van Tongeren
Journal:  Gut       Date:  1980-04       Impact factor: 23.059

10.  Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI).

Authors:  W R Best; J M Becktel; J W Singleton
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

View more
  35 in total

Review 1.  Current advantages in the application of proteomics in inflammatory bowel disease.

Authors:  Anna Vaiopoulou; Maria Gazouli; George Theodoropoulos; George Zografos
Journal:  Dig Dis Sci       Date:  2012-06-28       Impact factor: 3.199

2.  111In-oxine-labelled white blood cells in the diagnosis and follow-up of Crohn's disease.

Authors:  W Becker; W Fischbach; M Jenett; C Reiners; W Börner
Journal:  Klin Wochenschr       Date:  1986-02-03

3.  Elevated numbers of peripheral T cells in inflammatory bowel diseases displaying T9 antigen and Fc alpha receptors.

Authors:  A Raedler; S Fraenkel; G Klose; H G Thiele
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

Review 4.  Biomarkers in inflammatory bowel disease: current practices and recent advances.

Authors:  Heba N Iskandar; Matthew A Ciorba
Journal:  Transl Res       Date:  2012-02-01       Impact factor: 7.012

5.  Immunoglobulin G (IgG), IgG1, and IgG2 determinations from endoscopic biopsy specimens in control, Crohn's disease, and ulcerative colitis subjects.

Authors:  J Rüthlein; M Ibe; W Burghardt; J Mössner; I O Auer
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

6.  Plasma fibronectin in Crohn's disease.

Authors:  A Allan; J Wyke; R N Allan; P Morel; M Robinson; D L Scott; J Alexander-Williams
Journal:  Gut       Date:  1989-05       Impact factor: 23.059

7.  Predictors of acute relapse of Crohn's disease. A laboratory and clinical study.

Authors:  J P Wright; G O Young; N Tigler-Wybrandi
Journal:  Dig Dis Sci       Date:  1987-02       Impact factor: 3.199

8.  Role of the faecal stream in the maintenance of Crohn's colitis.

Authors:  P H Harper; E C Lee; M G Kettlewell; M K Bennett; D P Jewell
Journal:  Gut       Date:  1985-03       Impact factor: 23.059

9.  Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.

Authors:  C Cellier; T Sahmoud; E Froguel; A Adenis; J Belaiche; J F Bretagne; C Florent; M Bouvry; J Y Mary; R Modigliani
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

10.  Rates of whole body protein synthesis and breakdown increase with the severity of inflammatory bowel disease.

Authors:  J Powell-Tuck; P J Garlick; J E Lennard-Jones; J C Waterlow
Journal:  Gut       Date:  1984-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.